20/20 Biolabs, Inc. Common Stock

AIDXNASDAQ • USD
ThemeHealthcare - Oncology›Cancer Diagnostics & Biomarkers
0.80 USD
↘ 0.07 (7.75%)AT CLOSE (11:59 AM EDT)
0.89
↗ 0.09 (11.35%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
0.89
↗ 0.09 (11.35%)
🔴Market: CLOSED
Open?$0.87
High?$0.89
Low?$0.79
Prev. Close?$0.87
Volume?175.9K
Avg. Volume?N/A
VWAP?$0.84
Bid / Ask
Bid?$0.85 × 200
Ask?$0.92 × 300
Spread?$0.07
Midpoint?$0.88
Valuation & Ratios
Market Cap?8.5M
Shares Out?10.6M
Float?3.5M
Float %?64.7%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

20/20 Biolabs, Inc. Common Stock (AIDX) is currently trading at $0.80. Technical indicators currently signal "Sell".

Technical & fundamental data as of Jun 5, 2026.

News
Profile
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
Themes
Healthcare - Oncology›Cancer Diagnostics & BiomarkersAI & Machine Learning›AI-Powered Analytics & Decision SystemsLongevity & Aging›Age-Related Therapeutics
Employees
14
Market Cap
8.5M
Industry
SERVICES-TESTING LABORATORIES
Website
www.2020biolabs.com
Listed
2026-02-19
Address
9430 KEY WEST AVENUE
ROCKVILLE, MD 20850
Phone: (240) 453-6339
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.51%Low
Short Interest?18.1K
Days to Cover?1.0
Free Float3.5M
Avg Daily Volume70.8K
Settlement Date2026-05-15
MarketsMoversWatchlist